Role of APP and its Metabolites in Synaptic Degeneration
APP 及其代谢物在突触变性中的作用
基本信息
- 批准号:6344246
- 负责人:
- 金额:$ 44.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-05-01 至 2005-04-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer's disease amyloid proteins behavior test cognition disorders confocal scanning microscopy electrophysiology enzyme linked immunosorbent assay genetically modified animals hippocampus laboratory mouse light microscopy nerve /myelin protein neural degeneration neural transmission platelet derived growth factor protein structure function protein tyrosine kinase statistics /biometry synapses synaptophysin tissue /cell culture western blottings
项目摘要
Description (Provided by applicant): Neurological diseases that result in the
degeneration of synapses culminate in severe cognitive deficits and (behavioral
disturbances. These dementing illnesses present increasing medical and
socioeconomic problems and raise a wide range of fundamental neuroscientific
questions. Alzheimer's disease (AD) is the main cause of age-related dementia
and its prevalence is increasing rapidly due to the increasing number of
elderly in our population. AD is associated with a prominent degeneration of
synapses and with an abnormal accumulation of amyloid beta peptides (AB) in the
brain. A-beta is derived from the amyloid protein precursor (APP), which is
enriched in synapses. The precise relationship between APP, A-beta, and
synaptic loss remains obscure. The current proposal aims to shed light on this
relationship. We previously used the platelet-derived growth factor (PDGF) beta
chain promoter to express human APP (hAPP) in neurons of transgenic mice. In
these studies, we focused on the density of synaptophysin-immunoreactive
presynaptic terminals because the loss of these structures correlates well with
cognitive decline in AD. High levels of neuronal A-beta production in PDGF-hAPP
mice resulted in a decrease of presynaptic terminals and elicited major
deficits in synaptic transmission. In Aim 1, we will investigate whether the
profile of synaptic protein alterations in PDGF-hAPP mice resembles that in AD
brains, affecting some proteins more than others, and we will examine whether
these alterations are preceded or followed by changes in pre- or postsynaptic
neurons. In Aim 2, we will assess to what extent the development of synaptic,
alterations in PDGF-hAPP mice depends on the activity of the protein tyrosine
kinase Fyn, ablation of which has been shown to prevent A-beta-induced
neurotoxicity in tissue culture. In Aim 3, we will immunize PDGF-hAPP mice,
with A-beta to determine whether this approach can induce the clearance of
synaptotoxic A-beta species and inhibit synaptic degeneration. In Aim 4, we
will investigate the relationship between synaptic alterations and behavioral
deficits in PDGF-hAPP mice and determine whether the latter can also be
prevented or reversed by A-beta vaccination. Achieving these aims will help
assess the potential usefulness of novel therapeutic strategies for this most
prevalent neurodegenerative disorder. It will also advance our understanding of
the function of synaptic proteins in synapse loss and degeneration, which is
the focus of RFA NS-01-002.
描述(由申请人提供):神经系统疾病,导致
突触的退化最终导致严重的认知缺陷和(行为)
干扰.这些痴呆症目前越来越多的医疗和
社会经济问题,并提出了广泛的基础神经科学
问题.阿尔茨海默病(Alzheimer's disease,AD)是年龄相关性痴呆的主要病因
而且由于越来越多的
老年人在我们的人口。AD与一种显著的
突触和淀粉样β肽(AB)的异常积累,
个脑袋A-β衍生自淀粉样蛋白前体(APP),
富含突触APP、A-beta和
突触丢失仍然不清楚。目前的建议旨在阐明这一点
关系我们以前使用血小板衍生生长因子(PDGF)β
链启动子在转基因小鼠的神经元中表达人APP(hAPP)。在
在这些研究中,我们着重于突触素免疫反应性的密度,
突触前末梢,因为这些结构的丧失与
认知能力下降PDGF-hAPP中高水平的神经元A-β产生
小鼠导致突触前末梢减少,并引起主要的
突触传递的缺陷。在目标1中,我们将研究
PDGF-hAPP小鼠中突触蛋白改变的特征与AD中相似
大脑,影响某些蛋白质比其他更多,我们将研究是否
这些改变之前或之后是突触前或突触后神经元的变化。
神经元在目标2中,我们将评估突触,
PDGF-hAPP小鼠中的改变取决于蛋白酪氨酸的活性
激酶Fyn,其消融已显示可防止A-β诱导的
组织培养中的神经毒性。在目标3中,我们将免疫PDGF-hAPP小鼠,
与A-β,以确定这种方法是否可以诱导清除
突触毒性A-β种类并抑制突触变性。在目标4中,
将研究突触改变和行为之间的关系,
缺陷的PDGF-hAPP小鼠,并确定后者是否也可以
预防或逆转A β疫苗接种。实现这些目标将有助于
评估新的治疗策略的潜在有用性,
神经退行性疾病它也将促进我们对
突触蛋白在突触丧失和变性中的功能,
RFA NS-01-002的重点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lennart Mucke其他文献
Lennart Mucke的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lennart Mucke', 18)}}的其他基金
Transcriptomic and Proteomic Analysis of Tau-dependent E/I Imbalance
Tau 依赖性 E/I 失衡的转录组学和蛋白质组学分析
- 批准号:
10789541 - 财政年份:2023
- 资助金额:
$ 44.5万 - 项目类别:
Roles of TREM2 and TYROBP in AD-related Network Hyperexcitability
TREM2 和 TYROBP 在 AD 相关网络过度兴奋中的作用
- 批准号:
10718004 - 财政年份:2023
- 资助金额:
$ 44.5万 - 项目类别:
Project 3: Roles of Tau Levels, Sequence and Interactors in Neural Network Dysfunction of Alzheimer's Disease
项目 3:Tau 水平、序列和相互作用因子在阿尔茨海默病神经网络功能障碍中的作用
- 批准号:
10670346 - 财政年份:2021
- 资助金额:
$ 44.5万 - 项目类别:
Project 3: Roles of Tau Levels, Sequence and Interactors in Neural Network Dysfunction of Alzheimer's Disease
项目 3:Tau 水平、序列和相互作用因子在阿尔茨海默病神经网络功能障碍中的作用
- 批准号:
10461845 - 财政年份:2021
- 资助金额:
$ 44.5万 - 项目类别:
Project 3: Roles of Tau Levels, Sequence and Interactors in Neural Network Dysfunction of Alzheimer's Disease
项目 3:Tau 水平、序列和相互作用因子在阿尔茨海默病神经网络功能障碍中的作用
- 批准号:
10271128 - 财政年份:2021
- 资助金额:
$ 44.5万 - 项目类别:
Evolving CRISPR-based platforms for the discovery of Alzheimer relevant neurodegenerative pathways
不断发展的基于 CRISPR 的平台用于发现阿尔茨海默病相关的神经退行性通路
- 批准号:
10056618 - 财政年份:2020
- 资助金额:
$ 44.5万 - 项目类别:
Neural network and immune cell dysfunctions in Alzheimer's disease pathogenesis
阿尔茨海默病发病机制中的神经网络和免疫细胞功能障碍
- 批准号:
9766119 - 财政年份:2019
- 资助金额:
$ 44.5万 - 项目类别:
相似海外基金
Development of aggregation inhibition strategy for pathogenic amyloid proteins
致病性淀粉样蛋白聚集抑制策略的开发
- 批准号:
16H06216 - 财政年份:2016
- 资助金额:
$ 44.5万 - 项目类别:
Grant-in-Aid for Young Scientists (A)
Elucidation of the mechanisms on aggregation and toxicity of plant amyloid proteins which are toxic in the presence of metals
阐明在金属存在下有毒的植物淀粉样蛋白的聚集和毒性机制
- 批准号:
23380192 - 财政年份:2011
- 资助金额:
$ 44.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Demonstration of the abnormal conformational transition of amyloid proteins and it's application as an early diagnostic tool
淀粉样蛋白异常构象转变的演示及其作为早期诊断工具的应用
- 批准号:
21200072 - 财政年份:2009
- 资助金额:
$ 44.5万 - 项目类别:
Grant-in-Aid for Scientific Research on Innovative Areas (Research a proposed research project)
Metabolism of amyloid proteins and methods for detecting amyloid proteins
淀粉样蛋白的代谢和检测淀粉样蛋白的方法
- 批准号:
21790541 - 财政年份:2009
- 资助金额:
$ 44.5万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of aggregation disrupters for amyloid proteins
淀粉样蛋白聚集破坏剂的开发
- 批准号:
17310132 - 财政年份:2005
- 资助金额:
$ 44.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Inhibition of axonal transport of hippocampal neurons by amyloid proteins: relation to Alzheimer's disease
淀粉样蛋白抑制海马神经元轴突运输:与阿尔茨海默病的关系
- 批准号:
11670638 - 财政年份:1999
- 资助金额:
$ 44.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
RAB GTPASES AND TRAFFICKING OF BETA AMYLOID PROTEINS
RAB GTP 酶和 β 淀粉样蛋白的贩运
- 批准号:
6149928 - 财政年份:1998
- 资助金额:
$ 44.5万 - 项目类别: